Keyphrases
Active Surveillance
8%
Apparent Diffusion Coefficient
8%
Biopsy Naïve
13%
Clinical Suspicion
11%
Clinically Significant Prostate Cancer
34%
Data Systems
11%
Diagnostic Accuracy
9%
Diagnostic Performance
5%
Diffusion Coefficient Measurement
5%
Extracapsular Extension
6%
Final Pathology
5%
Gleason Grade Group
7%
Gleason Score
9%
Gleason Score 7
9%
Image Fusion
5%
Image-guided Biopsy
8%
Imaging Results
6%
Magnetic Resonance Imaging
17%
Magnetic Resonance Imaging Guided
10%
Magnetic Resonance Imaging-targeted Biopsy
5%
MRI-guided Biopsy
6%
Multiparametric MRI (mpMRI)
89%
Nave
15%
Prebiopsy
13%
Precancerous Lesions
7%
Prostate Biopsy
12%
Prostate Cancer
69%
Prostate Cancer Patients
5%
Prostate Cancer Screening
5%
Prostate Imaging Reporting
11%
Prostate-specific Antigen Density
11%
Prostate-specific Antigen Level
6%
Repeat Biopsy
16%
Reporting System
11%
Suspicious Lesions
5%
Targeted Biopsy
5%
Transrectal Biopsy
13%
Transrectal Ultrasound
9%
Tumor
5%
Medicine and Dentistry
Biopsy
73%
Diagnosis
7%
Diagnostic Accuracy
7%
Gleason Score
20%
Histopathology
8%
Magnetic Resonance Imaging
100%
Multiparametric Magnetic Resonance Imaging
27%
Neoplasm
7%
Prostate Biopsy
13%
Prostate Cancer
92%
Prostate Specific Antigen
19%
Prostatectomy
8%
Transrectal Ultrasonography
30%
